Pubblicazioni ufficiali Sanofi BOERSE MUENCHEN

Azioni

Tempo reale BOERSE MUENCHEN Altri mercati azionari 08:00:07 09/07/2024			Variaz. 5gg	Var. 1 gen.
92,79 ^EUR	+0,06%		+0,65%	+3,27%

08/07	Kymera comunica l'espansione della sperimentazione di KT-474; le azioni salgono dopo l'orario di lavoro	MT
08/07	Kymera Therapeutics, Inc. annuncia l'espansione degli studi di fase 2 su HS e AD di KT-474 (SAR444656), in seguito alla revisione intermedia di sicurezza ed efficacia	CI

Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	27/06	CO
Changes in management and corporate officers	21/06	CO
Changes in management and corporate officers	21/06	CO
Monthly statement on voting rights	31/05	CO
Monthly statement on voting rights	31/05	CO
Acquisition	30/05	CO
Acquisition	30/05	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	21/05	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	06/05	CO
Monthly statement on voting rights	30/04	CO
Monthly statement on voting rights	30/04	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	29/04	CO
1st quarter results	25/04	CO
1st quarter results	25/04	CO
Mixed general shareholder meeting	12/04	CO
Mixed general shareholder meeting	03/04	CO
Monthly statement on voting rights	31/03	CO
Monthly statement on voting rights	31/03	CO
Mixed general shareholder meeting	15/03	CO
Equities securities shareholders meeting notice	13/03	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	29/02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	26/02	CO
SEC Filing 20 F	23/02	CO
Universal registration document	23/02	CO